Statin-induced rhabdomyolysis from azithromycin interaction in a patient with heterozygous SLCO1B1 polymorphism.

Hailey BurnsLandon RussellZachary L Cox

Published in: Journal of clinical pharmacy and therapeutics (2020)

Patients with statin-induced myopathy associated with non-classic CYP inhibitors should be considered for genetic testing and alternative statins with less risk of future interactions.

Keyphrases

cardiovascular disease
high glucose
diabetic rats
coronary artery disease
acute kidney injury
drug induced
early onset
type diabetes
late onset
endothelial cells
current status
myasthenia gravis